Emkay's research report on Ashok Leyland
Despite muted volumes in 2Q, AL reported 100bps margin expansion to 11.6% on sustained pricing discipline, material cost controls, and growth in the non- MHCV portfolio. Management reiterated its optimism on CV industry demand in H2, and maintained its medium term mid-teen EBITDA margin guidance and 35% MHCV market share ambition. We expect CV industry volume to improve from H2 (aided by a more benign base and resumed infrastructure spends), and FY25E-27E volume CAGR in a mid-single-digit. We trim FY25E/25E/27E EPS by ~3%/2%/2%, building-in a more gradual margin improvement amid a softer economic outlook.
Outlook
We maintain BUY on AL and cut our SoTP-based TP to Rs275 (on 12.5x Sep-26E EV/EBITDA + 2x P/B for HLFL). AL is among the least expensive auto OEMs (12% EPS CAGR, net cash BS, >25% return ratios).
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.